Milestone Scientific Inc. (NYSE:MLSS) Director Leonard Osser Sells 107,984 Shares

Milestone Scientific Inc. (NYSE:MLSS) Director Leonard Osser sold 107,984 shares of the business’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the sale, the director now owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Leonard Osser also recently made the following trade(s):

• On Wednesday, August 21st, Leonard Osser sold 141,913 shares of Milestone Scientific stock. The stock was sold at an average price of $0.95, for a total value of $134,817.35.

Milestone Scientific Price Performance

Shares of NYSE:MLSS traded up $0.01 during midday trading on Wednesday, hitting $0.82. The company had a trading volume of 34,553 shares, compared to its average volume of 101,998. Milestone Scientific Inc. has a 12-month low of $0.52 and a 12-month high of $1.10. The company has a fifty day moving average of $0.94 and a two-hundred day moving average of $0.82. The company has a market cap of $63.02 million, a price-to-earnings ratio of -8.30 and a beta of 1.08.

Milestone Scientific (NYSE:MLSS) last posted its quarterly earnings data on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The company had revenue of $1.85 million during the quarter. Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on MLSS. Benchmark started coverage on Milestone Scientific in a research report on Thursday, October 10th. They issued a “speculative buy” rating and a $1.25 target price on the stock. StockNews.com started coverage on shares of Milestone Scientific in a report on Thursday, October 17th. They issued a “hold” rating on the stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.